Company intelligence / Profile preview

Centillion Technology

London, Greater London, United Kingdomcentillion-tech.com ↗

Ownership: Private
Employees: ~9
Development stage: Commercial

Overview

Centillion Technology has developed a patented manufacturing platform aimed at accelerating equitable access to RNA-based therapies and vaccines. There are no disclosed clinical results as the company's primary focus is enabling partners through its technology rather than advancing its own therapeutic pipeline.

Therapeutic areas: Other
Modalities: RNA therapymRNA-based drugs
Industry: Contract Manufacturing Organization

Partnerships

Centillion mentions a "rapidly growing network of RNA innovators and partners," but does not disclose specific names publicly.

Beyond the preview

Go deeper on Centillion Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Centillion Technology.

Explore the full profile